Galectin Therapeutics stock surges on FDA trial agreement
Investing.com Gold reports: Galectin Therapeutics stock surges on FDA trial agreement. Full body text was unavailable at ingest time, so this brief is based on headline context.
Investing.com Gold reports: Galectin Therapeutics stock surges on FDA trial agreement. Full body text was unavailable at ingest time, so this brief is based on headline context.